Previous Next Accountability The Problem With the FDA’s Quick-Approval Process for Drugs Abstract: A decade after the agency gave the nod to Makena, to prevent premature births, it’s not clear the medicine works. Publication: Bloomberg Date Published: March 27, 2020 Author(s): Emma Court View This Resource